Argenx
ARGX
#485
Rank
C$68.65 B
Marketcap
C$1,109
Share price
-1.38%
Change (1 day)
16.15%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

ESG Reports

Thumbnail Argenx
 ESG Report 2022

ESG Report 2022

Language: English

View ESG Report
Thumbnail Argenx
 ESG Report 2021

ESG Report 2021

Language: English

View ESG Report